Attached files
file | filename |
---|---|
S-1/A - AMENDMENT NO. 3 TO FORM S-1 - ARGOS THERAPEUTICS INC | d214145ds1a.htm |
EX-10.10 - FORM OF NONSTATUTORY STOCK OPTION AGREEMENT - ARGOS THERAPEUTICS INC | d214145dex1010.htm |
EX-10.8 - 2011 STOCK INCENTIVE PLAN - ARGOS THERAPEUTICS INC | d214145dex108.htm |
EX-10.28 - 2011 EMPLOYEE STOCK PURCHASE PLAN - ARGOS THERAPEUTICS INC | d214145dex1028.htm |
EX-10.9 - FORM OF INCENTIVE STOCK OPTION AGREEMENT - ARGOS THERAPEUTICS INC | d214145dex109.htm |
EX-3.2 - RESTATED CERTIFICATE OF INCORPORATION - ARGOS THERAPEUTICS INC | d214145dex32.htm |
EX-3.4 - AMENDED AND RESTATED BYLAWS - ARGOS THERAPEUTICS INC | d214145dex34.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1/A of Argos Therapeutics, Inc. of our report dated July 29, 2011 relating to the financial statements, which appears in such Registration Statement. We also consent to the references to us under the heading Experts in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Raleigh, North Carolina
January 6, 2012